Related Experiment Video
Updated: Aug 14, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
Lessons from COVID-19 for improving diagnostic access in future pandemics
Rosanna W Peeling1, Samuel K Sia2
1Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK. Rosanna.peeling@lshtm.ac.uk.
COVID-19 testing evolved significantly, yet equitable access and public health needs remained challenging. Lessons learned highlight the need for improved funding, adaptable technologies, data infrastructure, and streamlined regulatory processes for future diagnostic development.
Area of Science:
- Public Health
- Diagnostic Engineering
- Epidemiology
Background:
- The COVID-19 pandemic underscored the crucial role of diagnostic testing.
- Despite numerous test developments, challenges persisted in meeting public health demands and ensuring equitable access.
- Existing tests often fell short of the ideal 4As: accuracy, access, affordability, and actionability.
Purpose of the Study:
- To review the evolution of COVID-19 testing use cases throughout the pandemic.
- To identify engineering challenges and lessons learned for test developers at each phase.
- To propose future collaborative efforts for advancing diagnostic testing.
Main Methods:
- Literature review of testing strategies and their implementation during the COVID-19 pandemic.
- Analysis of engineering challenges encountered in test development and deployment.
- Synthesis of lessons learned and formulation of recommendations for future public health needs.
Main Results:
- Testing use cases dynamically shifted in response to pandemic phases.
- Significant engineering hurdles were encountered in scaling up production, ensuring accuracy, and achieving rapid results.
- Gaps in equitable access and alignment with public health objectives were consistently observed.
Conclusions:
- Future diagnostic test development requires new public sector funding models and R&D approaches.
- Investment in adaptable, open-platform technologies is essential for increasing testing capacity across healthcare.
- Robust data connectivity infrastructures are vital for integrated surveillance, and coordinated regulatory frameworks are needed for rapid innovation translation.
Related Concept Videos
Steps in Outbreak Investigation
Principles of Disease Surveillance
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...

